Status:
COMPLETED
Combined Drug Therapy in Lateral Fragility Fractures of the Femur
Lead Sponsor:
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
Conditions:
Femur Fracture
Eligibility:
All Genders
60-85 years
Brief Summary
It was conducted a prospective study with a series of 50 patients treated by intramedullary nail using Clodronic acid and Vitamin D (study group including 25 patients) and patients with the same fract...
Eligibility Criteria
Inclusion
- femur fractures type 31-A1, A2, (Muller ME, Nazarian S, Kock P et al.);
- age 60 - 85 years;
- co-operative patients;
- Body Mass Index (BMI) \< 30 Kg/m²;
- patients treated by intramedullary nailing surgery (PFNA Synthes®);
- patients with osteoporosis disease if T-Score\< -2,5;
Exclusion
- patients with heart, kidney, neurological diseases;
- patients with metabolic and systemic disease (rheumatoid arthritis, diabetes mellitus);
- previous surgery or severe osteoarthritis of lower limbs;
- specific drugs treatments such as anticoagulants or psychiatric drugs.
Key Trial Info
Start Date :
May 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05183308
Start Date
May 1 2019
End Date
March 1 2020
Last Update
February 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOUC Policlinico di Bari - UOC Ortopedia e Traumatologia
Bari, Italy, 70124